BAUSCH HEALTH COS INC (BHC:NYSE)

$4.83 -0.1 (-2.0284%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 56

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed BAUSCH HEALTH COS INC (BHC:NYSE) News Sources

Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth

18-05-2026

yahoo.com

external link

Bausch Health Announces 2026 Annual Meeting of Shareholder Results

19-05-2026

yahoo.com

external link

Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals

21-05-2026

yahoo.com

external link

Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China

28-05-2026

yahoo.com

external link

Bausch (BHC) Down 5.4% Since Last Earnings Report: Can It Rebound?

29-05-2026

yahoo.com

external link

Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia

09-06-2026

yahoo.com

external link

Michael Goettler Resigns from Bausch Health's Board of Directors

01-07-2026

yahoo.com

external link

Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia

06-07-2026

yahoo.com

external link

Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026

07-07-2026

yahoo.com

external link

Bausch Health’s (BHC) Canadian Subsidiary Lists PrOKEDI Dosages in RAMQ Formulary

12-07-2026

yahoo.com

external link

BAUSCH HEALTH COS INC (BHC:NYSE) Sentiment Trend

0 25 50 75 100 92 76 82 61 2 52 9 50 64 76 18-05-2026 19-05-2026 21-05-2026 28-05-2026 29-05-2026 09-06-2026 01-07-2026 06-07-2026 07-07-2026 12-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

BAUSCH HEALTH COS INC (BHC:NYSE) FAQs

toggle

What is the current price of BAUSCH HEALTH COS INC (BHC:NYSE)?

The current price of BAUSCH HEALTH COS INC (BHC:NYSE) is $4.83.


toggle

BAUSCH HEALTH COS INC (BHC:NYSE) absolute price change since previous trading day?

The absolute price change of BAUSCH HEALTH COS INC (BHC:NYSE) since the previous trading day is $-0.1.


toggle

BAUSCH HEALTH COS INC (BHC:NYSE) percentage price change since previous trading day?

The percentage price change of BAUSCH HEALTH COS INC (BHC:NYSE) since the previous trading day is -2.0284%.


toggle

What is the most recent average sentiment score for BAUSCH HEALTH COS INC (BHC:NYSE)?

The most recent average sentiment score for BAUSCH HEALTH COS INC (BHC:NYSE) is 56 out of 100.


toggle

What is the most recent average sentiment for BAUSCH HEALTH COS INC (BHC:NYSE)?

The most recent sentiment for BAUSCH HEALTH COS INC (BHC:NYSE) is .


SEC-8K** Filing Available For BAUSCH HEALTH COS INC (BHC:NYSE)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

BW-A (Babcock & Wilcox Enterprises Inc)
BWNB (Babcock & Wilcox Enterprises Inc 6.50%)
BWSN (Babcock & Wilcox Enterprises Inc)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.